NASDAQ:RCPT (RCPT) (RCPT) Stock Price, News & Analysis → 😱 This phenomenon is smashing regular market gains (From MillPub) (Ad) Free RCPT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (RCPT) alerts: Email Address Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. About (RCPT) Stock (NASDAQ:RCPT)Receptos, Inc. (Receptos) is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing therapeutics in immune disorders. Its product candidates span three disease areas. It is developing its lead asset, ozanimod (formerly RPC1063), as an oral therapy for the treatment of Relapsing Multiple Sclerosis (RMS) and Inflammatory Bowel Disease (IBD), which consists of Ulcerative Colitis (UC) and Crohn’s Disease (CD). It is developing its second asset, RPC4046, for the treatment of an allergic/immune-mediated disorder, Eosinophilic Esophagitis (EoE), for which it has been granted Orphan drug designation. Its research efforts include a preclinical program developing oral, small molecule, positive allosteric modulators (PAMs) of the glucagon-like peptide-1 receptor (GLP-1R) for the treatment of Type 2 Diabetes.Read More Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. RCPT Stock News HeadlinesNovember 6, 2023 | msn.comPolice searching for east Tulsa nightclub shooting suspectOctober 22, 2023 | msn.comWorld champion Leigh Wood confirms next career move with social media postMay 1, 2024 | MillPub (Ad)😱 This phenomenon is smashing regular market gainsThanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.April 14, 2023 | msn.comDramatic Change In Weather Pattern Could Bring Some Snow To Parts Of NortheastApril 4, 2023 | msn.comOne killed in train accident near The Hague, 30 injuredMarch 28, 2023 | thestreet.comReceptos (RCPT) Stock Surging on $7.2 Billion Takeover DealMarch 9, 2023 | msn.comAll disabled Root of Nightmare weapons, mods, and gear in Destiny 2’s World First race and Contest ModeMarch 9, 2023 | msn.comWorld Kidney Day holds special meaning to Winterport kid who was on a donor list for eight hoursMay 1, 2024 | MillPub (Ad)😱 This phenomenon is smashing regular market gainsThanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.February 16, 2023 | msn.comIndian Railways cancels 443 trains today; complete list of trains cancelled, diverted on 17 February 2023February 15, 2023 | msn.comIndian Railways cancels over 450 trains today: Complete list of trains cancelled, diverted by on 15 February 2023February 3, 2023 | msn.comIndian Railways cancels 323 trains today: Complete list of trains cancelled, diverted on 4 February, 2023January 25, 2023 | thestreet.comJim Cramer's Top Stock Picks: NVAX TGT BMRN RCPTJanuary 17, 2023 | msn.comWill the Doomsday Clock Move Closer to Midnight? Watch Live OnlineDecember 19, 2022 | msn.comTV and Streaming Viewing Picks for December 19, 2022: how to watch Monday Night FootballOctober 29, 2022 | msn.comToddlers to get free vaccinesSeptember 29, 2022 | msn.comThe row over plans to transform part of a historic castle estate into apartmentsSeptember 15, 2022 | msn.com‘It’d be a huge deal’: NCAA visits Sacramento amid Women’s Final Four biddingSeptember 15, 2022 | msn.comThink history class is boring? You haven't been in Mr. Flint's class at Westside High SchoolAugust 8, 2022 | msn.comBeth Dobbin says relay bronze for Scotland 'bittersweet' after England disqualificationJuly 18, 2022 | benzinga.comSPCG PCL NON-VTG DEP RCPT by SPCG Public Co Ltd (OTC:SPCGF), Guidance and ForecastJuly 18, 2022 | benzinga.comSPCG PCL NON-VTG DEP RCPT by SPCG Public Co Ltd (OTC:SPCGF), Analyst Ratings, Price Targets, PredictionsJuly 4, 2022 | thestreet.comJim Cramer's Top Stock Picks: CLH, RCPT, MNST, ROSTJuly 3, 2022 | thestreet.comJim Cramer's 'Mad Money' Recap: We're Not Out of the Woods YetJune 16, 2022 | msn.comHow to Set Up a Postfix Mail Server on DebianFebruary 20, 2022 | techrepublic.comResolving mail server problems with Nslookup and TelnetSee More Headlines Receive RCPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (RCPT) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:RCPT CUSIPN/A CIK1463729 Webreceptos.com Phone+1-858-6525700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report RCPT Stock Analysis - Frequently Asked Questions What other stocks do shareholders of (RCPT) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (RCPT) investors own include Omeros (OMER), Esperion Therapeutics (ESPR), Regeneron Pharmaceuticals (REGN), Gilead Sciences (GILD), Intercept Pharmaceuticals (ICPT), bluebird bio (BLUE), OPKO Health (OPK), Vertex Pharmaceuticals (VRTX) and Agios Pharmaceuticals (AGIO). This page (NASDAQ:RCPT) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersElon’s New Device is About to Shock the WorldInvestorPlace😱 This phenomenon is smashing regular market gainsMillPubYour bank is lying to you.MyBankTrackerDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget Nvidia. This is the future of AIPorter & CompanyBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (RCPT) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
